Utah State Board of Education rejects proposed letter supporting President Trump's recent actions to dismantle the Department of Education. Some board members argue Utah is equipped to manage key education programs — others disagree.

In over 1,000 cities, including at all 50 state capitols, the U.S. Capitol and in Puerto Rico, people unhappy with the Trump administration are gathering to protest “everything” on Saturday. Organizers say at least 250,000 people across the country have RSVP’d so far, per Axios.

Those five countries account for more than two-thirds of all products shipped to Utah. Each of them face hefty new trade levies: U.

State school board member Cole Kelley co-sponsors letter up for board approval that supports Trump's efforts to dismantle Education Department.

Former ambassador Jeff Flake said the trade mission led by Gov. Spencer Cox will help Utah companies navigate the current economic environment.

The Utah State Board of Education on Thursday rejected a proposal from some of its members to send a letter to President Donald Trump formally supporting the elimination of the U.S. Department of Education.

Kavya Beheraj/Axios Protestors in cities and towns across Utah are planning to join Saturday's nationwide "Hands Off!" demonstrations against the Trump administration. Why it matters: It's expected to be the largest single-day protest since Trump took office.

A powerful member of the Federal Trade Commission has been working her high-profile post remotely – despite President Trump’s demands that federal employees show up to the office five days a

Federal funding holds implemented by the Trump administration have hit a handful of planned Utah transportation projects, including those aiming to build safer streets and better connections to transit.

In a recent spree of clemency for white collar criminals, President Trump has pardoned Utah entrepreneur Trevor Milton, who was convicted in 2022 of misleading investors in his hydrogen and electric truck company Nikola.

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs.